The authors report that a pooled analysis by the NCCTG shows that conducting trials specifically for older patients is appropriate cancer care, targets patients otherwise not studied, and does not compete with accrual in other trials.
This article shows that a comprehensive geriatric assessment (CGA) is better than the American Society of Anesthesiologists (ASA) physical status system at predicting 30-day postoperative morbidity. These two articles address the underaccrual of older patients to clinical trials. In the first article, the Cancer and Leukemia Group B (CALGB) conducted a randomized study of an educative intervention targeting physicians, which unfortunately was unsuccessful. In the second article, the authors postulated that the most effective way to improve accrual is to broaden comorbidity restrictions. The first article, by a task force from the International Society of Geriatric Oncology (SIOG), reviews evidence on the use of a comprehensive geriatric assessment. The second article offers recommendations concerning the multicultural aspect of caring for the older cancer patient.
